Table 1.
Patient characteristics
| Characteristic | All (n=126) | Colorectal (n=71) | Non-colorectal (n=55) |
|---|---|---|---|
| Age, median (range, yr) | 65.4 (33-87) | 67.1 (33-84) | 63.4 (44-87) |
| Female sex | 54 (42.9) | 16 (22.5) | 38 (69.1) |
| Tumor entities | |||
| Colorectal cancer | 71 (56.3) | 71 (100) | - |
| Gastrointestinal, non-CRC | 13 (10.3) | - | 13 (23.6) |
| Breast | 14 (11.1) | - | 14 (25.5) |
| Uro-genital | 15 (11.9) | - | 15 (27.3) |
| Bronchial | 5 (4.0) | - | 5 (9.1) |
| Liver | 1 (0.8) | - | 1 (1.8) |
| Others | 8 (6.3) | - | 8 (14.5) |
| Systemic pretreatment | 103 (81.7) | 62 (87.3) | 41 (74.5) |
| Local pretreatment | 95 (75.4) | 53 (74.6) | 42 (76.4) |
| Toolbox | 33 (26.2) | 18 (25.4) | 15 (27.3) |
| Thermal ablation (RFA, MW) | 13 (10.3) | 10 (14.1) | 3 (5.5) |
| SBRT | 13 (10.3) | 6 (8.5) | 7 (12.7) |
| SIRT | 7 (5.6) | 2 (2.8) | 5 (9.1) |
| Liver surgery | 85 (67.5) | 46 (64.8) | 39 (70.9) |
| Follow-up (95% CI, mo) | 30 (19.3-40.8) | 34.7 (22.3-47.2) | 28 (4.9-51.1) |
Values are presented as number (%) unless otherwise indicated. CRC, colorectal cancer; RFA, radiofrequency ablation; MW, microwave ablation; SBRT, stereotactic body radiation treatment; SIRT, selective internal radiation therapy; CI, confidence interval.